Global Asthma Devices Market Overview:
Asthma is a Common Lung Condition that Causes Irregular Breathing Problems. Asthma is Caused by the Inflammation and Contraction of the Tubes that Carry Air to and from the Lungs. Breathlessness, Coughing, and Wheezing are some of the Common Symptoms of Asthma. It Often Starts in Childhood, Although It Can Also Develop in Adults, and Affects People of All Ages. Asthma is The Most Prevalent Chronic Disease Among Children Worldwide. According to the World Health Organization’s Report, Around 235 Million People Globally are Living With Asthma. Asthma is Incurable, But Manageable With Proper Medications, Medical Devices, and Lifestyle Modifications. Some of the key players profiled in the study are Novartis (Switzerland), GlaxoSmithKline (United Kingdom), Adamis Pharmaceuticals Corporation (United States), Boehringer Ingelheim International Gmbh (Germany), Philips (Netherlands), AstraZeneca Plc (United Kingdom), Cipla Limited (India), Aradigm Corporation (United States), Chiesi Farmaceutici Spa (Italy) and Adherium Limited (New Zealand).
On the basis of geography, the market of Asthma Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by User, the sub-segment i.e. Adults will boost the Asthma Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technology, the sub-segment i.e. Manual will boost the Asthma Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sales Channel, the sub-segment i.e. Pharmacy Stores will boost the Asthma Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Presence of Large Population Suffering from Acute and Chronic Asthma Owing to Numerous Factors Like Air Pollution, Smoking, and Unhealthy Lifestyle.
- Technological Advancement in Healthcare Treatments Facilitating Effective Asthma Management
Market Trend
- Introduction of Battery Powered, Rechargeable Nebulizers that Transform Medication into Ultra-Fine Droplets for Effective and Efficient Penetration to Lungs
Restraints
- Unawareness about the Easy and Affordable Accessibility of Asthma Treatment in Many Locations.
Opportunities
- Owing to The Rise in Pulmonary Diseases Like Asthma in Rising Economies due to Heavy Industrialization, There is an Increased Necessity for Asthma Devices.
- There is a Growing Prospect for Pharmaceutical Companies and Healthcare Start-Ups to Manufacture Asthma Devices for the Surging Number of Asthma Patients Worldwide.
Challenges
- Improper Inhaler Usage Especially Amongst Children Poses a Challenge and can Contribute to Poor Asthma Control.
Major Market Developments:
In April 2019, Cipla launched Niveoli™, India’s first extra-fine particle Beclomethasone Formoterol combination Hydrofluoroalkane (HFA) inhaler for adults, targeting drug delivery to the small airways. and In January 2019, the United States Food and Drug Administration (USFDA) announced its approval for the world’s first digital inhaler “Proair Digihaler” (Teva pharmaceutical industries) for the management of asthma.
In November 2019, Novartis announced that it has entered into an agreement and plan of merger with the medicines company (United States) and In January 2018, GlaxoSmithKline successfully completed its acquisition of Tesaro, an oncology-focused company through its wholly-owned subsidiary Adriatic acquisition corporation.
The Asthma Devices market is moderately fragmented with the presence of many players worldwide. Some of the leading players are adopting some organic and inorganic strategies such as a merger, acquisition, expansion, new product launches, among others in order to gain leading share within the market. Owing to the supportive government regulations there are massive opportunities emerging for the new entrants.
Target Audience:
Pharmaceuticals Companies, Medical Research Laboratories, Investors, Distributors/Traders, Importers/Exporters, Regulatory and Government Bodies, Downstream Vendors, Up-Stream Vendors, End Users and Others
Major Objectives Focused through this Study
To define, describe, and forecast the Global Asthma Devices market on the basis of product [Inhalers(Metered Dose Inhalers, Dry Powder Inhalers, and Soft Mist Inhalers), Nebulizers(Compressor Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) and Others] , application [Hospitals, Clinics, Home Care and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Asthma Devices market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Asthma Devices industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Gerresheimer (Germany), Cohero Health (United States), Devilbiss Healthcare Llc (United States), Ge Healthcare (United States), Gilbert Technologies (Holland), Gerresheimer (Germany), Medisol Lifescience Pvt. Ltd. (India), Mylan (United States), Orion Corporation (Finland), Sunovion Pharmaceuticals Inc. (United States) and Teva Pharmaceuticals Industries Ltd. (Israel).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Asthma Devices market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.